| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $27.0B | $24.5B | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $6.2B | $5.8B | $5.3B | $4.3B | $4.3B | $0.6B | $0.6B | $0.6B |
| Net Income | $4.2B | $4.1B | $3.8B | $3.0B | $3.1B | $0.4B | $0.4B | $0.2B |
| EPS (Basic) | $8.48 | $8.26 | $7.60 | $6.11 | $6.20 | $0.74 | $0.77 | $0.30 |
| EPS (Diluted) | $8.43 | $8.18 | $7.53 | $6.04 | $6.13 | $0.73 | $0.76 | $0.30 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $58.7B | $56.5B | $48.0B | $33.5B | $34.4B | $33.0B | $31.4B | $21.6B |
| Current Assets | $23.2B | $22.1B | $21.7B | $8.3B | $8.3B | $8.2B | $7.1B | $5.9B |
| Cash & Equivalents | $2.7B | $2.4B | $3.4B | $1.4B | $1.8B | $2.1B | $1.2B | $1.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $21.1B | $19.5B | $19.8B | $7.2B | $6.7B | $6.6B | $6.7B | $4.9B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.3B | $4.3B | $4.3B | $3.5B | $3.5B | $3.4B | $2.4B | $2.4B |
| Investing Cash Flow | $-0.8B | $-8.8B | $-1.4B | $-0.8B | $-1.2B | $-0.8B | $-5.7B | $-1.1B |
| Capital Expenditures | $0.3B | $0.3B | $0.4B | $0.5B | $0.4B | $0.3B | $0.4B | $0.3B |
| Financing Cash Flow | $-4.6B | $4.5B | $-1.1B | $-1.0B | $-1.3B | $-1.9B | $3.3B | $-1.3B |